Free Trial
NASDAQ:CLVR

Clever Leaves (CLVR) Stock Price, News & Analysis

Clever Leaves logo
$0.0004 0.00 (0.00%)
As of 05/21/2025

About Clever Leaves Stock (NASDAQ:CLVR)

Key Stats

Today's Range
$0.0004
$0.0004
50-Day Range
N/A
52-Week Range
$0.00
$3.55
Volume
29 shs
Average Volume
1,913 shs
Market Capitalization
$702.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.

Receive CLVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clever Leaves and its competitors with MarketBeat's FREE daily newsletter.

CLVR Stock News Headlines

AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Clever Leaves Holdings Inc.
See More Headlines

CLVR Stock Analysis - Frequently Asked Questions

Clever Leaves' stock was trading at $0.0002 at the beginning of 2025. Since then, CLVR shares have increased by 100.0% and is now trading at $0.0004.
View the best growth stocks for 2025 here
.

Shares of Clever Leaves reverse split on the morning of Friday, August 25th 2023. The 1-30 reverse split was announced on Thursday, August 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Shares of CLVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clever Leaves investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Advanced Micro Devices (AMD) and Salesforce (CRM).

Company Calendar

Today
5/22/2025
Next Earnings (Estimated)
5/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CLVR
Fax
N/A
Employees
560
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$17.42 million
Price / Cash Flow
N/A
Book Value
$14.02 per share
Price / Book
0.00

Miscellaneous

Free Float
1,611,000
Market Cap
$702.00
Optionable
No Data
Beta
3,571.18
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:CLVR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners